Genetics and variability in opioid response

European Journal of Pain

Volumn 9, Issue 2 SPEC. ISS., 2005, Pages 101-104

  Stamer, Ulrike M ^a   Bayerer, Bettina ^a   Stüber, Frank ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Codeine; Drug metabolizing enzymes; Opioid receptors; Pharmacogenetics; Tramadol

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CODEINE; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; DIAZEPAM; DIPYRONE; DRUG METABOLITE; DRUG METABOLIZING ENZYME; GLYCOPROTEIN P; HALOPERIDOL; ISONIAZID; METOCLOPRAMIDE; MORPHINE; MORPHINE 6 GLUCURONIDE; NONSTEROID ANTIINFLAMMATORY AGENT; O NORTRAMADOL; OMEPRAZOLE; OPIATE; OPIATE RECEPTOR; PARACETAMOL; PHENYTOIN; PROTON PUMP INHIBITOR; SEROTONIN 3 ANTAGONIST; TOLBUTAMIDE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; WARFARIN;

ANALGESIA; ARTICLE; ATAXIA; BLEEDING; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DRUG EFFICACY; DRUG METABOLISM; DRUG OVERDOSE; DRUG RESPONSE; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEALTH CARE COST; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; NAUSEA; NEUROTOXICITY; NOCICEPTION; PAIN; PARKINSONISM; PERIPHERAL NEUROPATHY; PHARMACOGENETICS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT; TREATMENT OUTCOME; TUBERCULOSIS; VOMITING;

EID: 14644425293     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpain.2004.05.008     Document Type: Article

References (15)

1. K. Befort, D. Filliol, F.M. Decaillot, C. Gaveriaux-Ruff, M.R. Hoehe, and B.L. Kieffer A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling J. Biol. Chem. 276 2001 3130 3137
2. A.K. Daly, J. Brockmoller, F. Broly, M. Eichelbaum, W.E. Evans, and F.J. Gonzalez Nomenclature for human CYP2D6 alleles Pharmacogenetics 6 1996 193 201
3. K. Eckhardt, S. Li, S. Ammon, G. Schanzle, G. Mikus, and M. Eichelbaum Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation Pain 76 1998 27 33
4. R. Kaiser, O. Sezer, A. Papies, S. Bauer, C. Schelenz, and P.B. Tremblay Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes J. Clin. Oncol. 20 2002 2805 2811
5. T. Koch, T. Kroslak, M. Averbeck, P. Mayer, H. Schroder, and E. Raulf Allelic variation S268P of the human mu-opioid receptor affects both desensitization and G protein coupling Mol. Pharmacol. 58 2000 328 334
6. J. Lazarou, B.H. Pomeranz, and P.N. Corey Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies JAMA 279 1998 1200 1205
7. J. Lötsch, C. Skarke, S. Grosch, J. Darimont, H. Schmidt, and G. Geisslinger The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine Pharmacogenetics 12 2002 3 9
8. J. Lötsch, M. Zimmermann, J. Darimont, C. Marx, R. Dudziak, and C. Skarke Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity? Anesthesiology 97 2002 814 819
9. L. Poulsen, K. Brosen, L. Arendt-Nielsen, L.F. Gram, K. Elbaek, and S.H. Sindrup Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects Eur. J. Clin. Pharmacol. 51 1996 289 295
10. L. Poulsen, L. Arendt-Nielsen, K. Brosen, and S.H. Sindrup The hypoalgesic effect of tramadol in relation to CYP2D6 Clin. Pharmacol. Ther. 60 1996 636 644
11. R.B. Raffa, E. Friderichs, W. Reimann, R.P. Shank, E.E. Codd, and J.L. Vaught Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol J. Pharmacol. Exp. Ther. 267 1993 331 340
12. Rittner HL, Stein C. Involvement of cytokines, chemokines and adhesion molecules in opioid analgesia. Eur J Pain, this issue, in press, doi:10.1016/j.ejpain.2004.05.009
13. C. Sachse, J. Brockmoller, S. Bauer, and I. Roots Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences Am. J. Hum. Genet. 60 1997 284 295
14. U.M. Stamer, K. Lehnen, F. Höthker, B. Bayerer, S. Wolf, and A. Hoeft Impact of CYP2D6 genotype on postoperative tramadol analgesia Pain 105 2003 231 238
15. S. Sunahara, M. Urano, and M. Ogawa Genetical and geographic studies on isoniazid inactivation Science 134 1961 1530 1531